Yuhao Xie

ORCID: 0000-0003-0319-8270
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Protein Structure and Dynamics
  • RNA modifications and cancer
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Ferroptosis and cancer prognosis
  • Advanced ceramic materials synthesis
  • Polymer composites and self-healing
  • Protein purification and stability
  • Machine Learning in Bioinformatics
  • Concrete and Cement Materials Research
  • vaccines and immunoinformatics approaches
  • Photopolymerization techniques and applications
  • Food Industry and Aquatic Biology
  • Smart Materials for Construction
  • Plant pathogens and resistance mechanisms
  • Epoxy Resin Curing Processes
  • Lignin and Wood Chemistry
  • Lipid metabolism and biosynthesis
  • Pharmacological Effects and Toxicity Studies
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Military Defense Systems Analysis
  • Microbial Natural Products and Biosynthesis
  • PI3K/AKT/mTOR signaling in cancer
  • Ocular Oncology and Treatments
  • Histone Deacetylase Inhibitors Research

St. John's University
2022-2025

Beijing University of Chinese Medicine
2025

Jiangxi Science and Technology Normal University
2024

Northeast Electric Power University
2024

Nanjing University of Science and Technology
2023

University of California, Santa Barbara
2022

Chengdu University of Technology
2022

Shandong University
2021

Nanchang University
2018-2021

China Building Materials Academy
2021

Breast cancer, a complex and varied disease, has four distinct subtypes based on estrogen receptor human epidermal growth factor 2 (HER2) levels, among which significant subtype known as HR+/HER2-breast cancer that spurred numerous research. The prevalence of breast cancer-related death are the most serious threats to women’s health worldwide. Current progress in treatment strategies for encompasses targeted therapy, endocrine genomic immunotherapy, supplementing traditional methods like...

10.3389/fphar.2024.1340764 article EN cc-by Frontiers in Pharmacology 2024-01-24

Abstract Background and Objectives Actin-related protein 2/3 complex subunit 1B (ARPC1B) is an essential of the actin-related (Arp2/3) complex. While there have been numerous research reports on Arp2/3 in relation to tumors, needs be more ARPC1B its role particularly at pan-cancer level. Methods Utilizing data from cancer genome atlas (TCGA) genotype-tissue expression (GTEx) databases, we analyzed differences normal, tumor, adjacent tissues, investigating correlation with prognosis clinical...

10.2478/jtim-2024-0025 article EN Journal of Translational Internal Medicine 2024-09-01

Background/Objectives: Hyperlipidemia (HLP) encompasses a spectrum of poorly understood lipid metabolism disorders that are frequently overlooked or misdiagnosed, potentially leading to multiple complications. While the gut microbiota has been implicated in HLP pathogenesis, causal relationships and molecular mechanisms remain elusive. This study aimed investigate therapeutic Monascus-fermented ginseng (MFG) on through modulation explore treatment potential via fecal transplantation (FMT)....

10.3390/ph18050661 article EN cc-by Pharmaceuticals 2025-04-30

Abstract Prediction of protein complex structures and interfaces potentially has wide applications can benefit the study biological mechanisms involving protein-protein interactions. However, surface prediction accuracy traditional docking methods AlphaFold-Multimer is limited. Here we present ColabDock, a framework that makes use ColabDesign, but reimplements it for purpose restrained conformation prediction. With generation-prediction architecture trained ranking model, ColabDock...

10.1101/2023.07.04.547599 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2023-07-04

Abstract The influence of steel fiber on the mechanical properties ultra-high performance concrete (UHPC) were studied through slump, compressive strength, flexural strength test. experimental results showed that incorporation had an working UHPC, and slump expansion degree UHPC inversely proportional to volume content length-diameter ratio fiber. significantly improved UHPC. property was best when 4%, with 28 day up 163.2MPa 45.9MPa. a trend gradual decrease increase aspect condition...

10.1088/1757-899x/1167/1/012001 article EN IOP Conference Series Materials Science and Engineering 2021-07-01

Micromorphology, surface property, chemical structure and size distribution of self-healing microcapsules were characterized by ESEM, plasmon resonance analyzer, FTIR standard sieve shaker. The yield core content determinated. results showed that reaction between resorcinol UF resin shell materials could promote the polymerization particles enhance degree cross-linking materials. Particle microcapsule roughness increase with increasing degrees in resin. initially rose then decreased...

10.1080/10667857.2018.1522474 article EN Materials Technology 2018-09-13

The U.S. Food and Drug Administration (FDA) first approved amivantamab, a monoclonal epidermal growth factor receptor (EGFR)-mesenchymal--epithelial transition (MET) bispecific antibody, in May 2021, to treat adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) an insertion mutation exon 20 of EGFR. approval amivantamab represents targeted therapy for this subtype NSCLC. In contrast other drugs that inhibit the tyrosine kinase activity protein, EGFR, has...

10.1358/dot.2022.58.8.3432777 article EN Drugs of today 2022-08-01
Coming Soon ...